Intellectual Property Transactions

EMA professionals have served in an advisory capacity on the following transactions:


  • Represented One Lambda, Inc. in licensing agreement with Luminex Corporation. Terms undisclosed.
  • Sale of IP assets of Cee-Jay Tool, Inc., a manufacturer of stone cutting and splitting equipment, to Springs Fabrication, Inc. Terms undisclosed.
  • Represented BioMicro Systems, Inc. in its sale of intellectual property assets relating to IGOR systems to IRIS International. Terms undisclosed.
  • Represented BioMicro Systems, Inc. in its sale of all intellectual property assets relating to NimbleGen microarrays to Roche Diagnostics. Terms undisclosed.
  • Negotiation of license, joint development and distribution agreements with Sigma-Aldrich Corporation (SIAL) on behalf of early-stage biomarker and reagent company. Terms undisclosed.
  • Represented a $50 million revenue life sciences instrumentation and reagent company through multiple transactions, 9 in-licensing and acquisition projects, and the divestiture of one business unit. Terms undisclosed.
  • Negotiation of joint venture and licensing agreement with microfluidics company. Terms undisclosed.
  • Negotiation of license agreement with Luminex, Inc. (LMNX). Terms undisclosed.
  • Negotiation of license agreement for biomarker technology with Scripps Institute. Terms undisclosed.
  • Negotiation of license and distribution agreement for gene expression technology with Bayer Healthcare, LLC, Diagnostics Division. Terms undisclosed.
  • Negotiation of license agreement for fluorescent marker technology with Albert Einstein College of Medicine. Terms undisclosed.
  • Sale of First Opinion Corporation, a healthcare diagnostics software company with a robust patent portfolio in the arena of automated diagnosis, to Healthways, Inc. (HWAY). Transaction valued at $26 million.
  • Negotiation of license agreement with Robert Bosch North America Corporation on behalf of Healthways, Inc. (HWAY). Terms undisclosed.
  • Negotiation of joint venture technology development agreements with multi-billion dollar medical device manufacturer. Terms undisclosed.
  • Negotiation of technology license agreements with The University of North Carolina at Chapel Hill, and the Centre National De Recherche Scientifique (CNRS). Terms undisclosed.

Back to Sectors